EPS15 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 6.2117000432238E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.16830000013368E-07 |
Normal-vs-Stage2 |
2.797300E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.386030E-01 |
Stage1-vs-Stage2 |
5.169800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
3.562100E-02 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
1.758200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.57340000420214E-08 |
Normal-vs-AfricanAmerican |
8.742500E-02 |
Normal-vs-Asian |
9.976300E-02 |
Caucasian-vs-AfricanAmerican |
3.230200E-02 |
Caucasian-vs-Asian |
7.501800E-01 |
AfricanAmerican-vs-Asian |
1.439180E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.371470E-04 |
Normal-vs-Female |
1.19830000000487E-06 |
Male-vs-Female |
2.335000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.622310E-02 |
Normal-vs-Extreme_Weight |
4.42239999998151E-06 |
Normal-vs-Obese |
1.267680E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.459600E-02 |
Normal_Weight-vs-Obese |
3.455200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.120800E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.012000E-01 |
Normal-vs-Age(41-60Yrs) |
3.143300E-03 |
Normal-vs-Age(61-80Yrs) |
4.49169999972021E-07 |
Normal-vs-Age(81-100Yrs) |
3.529000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.915200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.984800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.791600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.297000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.604000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.691200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.586190E-01 |
Normal-vs-Grade 3 |
1.417560E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.983400E-01 |
Grade 2-vs-Grade 4 |
1.586190E-01 |
Grade 3-vs-Grade 4 |
1.417560E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.36870000280831E-08 |
Normal-vs-N1 |
7.934500E-02 |
N0-vs-N1 |
3.504400E-01 |
|
|